Skip to content

Trusha Tullu

Interventional Psychiatry Program, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.

1 paper in the library · 22 citations · publishing 2025

Papers

Pharmacokinetics of Psilocybin: A Systematic Review

Pharmaceutics March 25, 2025 Shakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris et al. 22 citations

Psilocybin is rapidly converted to its active metabolite psilocin after oral intake. Psilocin reaches peak concentration in blood plasma between 1.8 and 4 hours, with maximum concentration ranging from 8.2 ng/mL in plasma to 871 ng/mL in urine, depending on dose. Its bioavailability is about 53%, and it distributes extensively into tissues, with volume of distribution between 277 and 1016 liters. Metabolism involves CYP2D6 and CYP3A4 enzymes, plus monoamine oxidase A, producing 4-hydroxyindole-3-acetic acid and 4-hydroxytryptophol. Elimination half-life ranges from 1.5 to 4 hours. These pharmacokinetics vary with dosage, route, and species, and the role of CYP enzymes indicates possible drug interactions.